Thyroid problems at any time during a woman's pregnancy are associated with pregnancy-related complications and may be detrimental to the infants neural development, said the American Thyroid Association (ATA) in a statement released recently. This information was echoed by other experts in thyroid diseases and fetal and womens health at a recent symposium sponsored by the the ATA and the American Association of Clinical Endocrinologists (AACE).
In addition, the ATA statement calls for prospective studies looking at population screening and treatment of asymptomatic or subclinical hypothyroidism, also known as an underactive thyroid. The organization of thyroid specialists also proposes public education initiatives, including messages about maternal thyroid health in over-the-counter pregnancy test kits.
The April 2 symposium in Alexandria, Va., titled The Impact of Maternal Thyroid Status on Pregnancy and Fetal and Childhood Development, brought together top researchers and clinicians in obstetrics and gynecology, neonatology, and thyroid diseases to explore important clinical and policy issues to educate caregivers about the best diagnosis, treatment, and monitoring strategies as well as public policy issues that influence how care is provided.
"Maternal hypothyroidism and autoimmune thyroid disease like Hashimoto's thyroiditis, a type of hypothyroidism, or underactive thyroid increase the risk of pregnancy complications, such as miscarriage, prematurity, gestational hypertension, and pre-eclampsia, as well as deficits of intellectual development in children," said Stephen H. LaFranchi, MD, of the Oregon Health & Science University in Portland, Ore., and a co-chair of the symposium. "The symposium tackled many unresolved issues, such as whether it is time to consider pilot screening programs of women for maternal hypothyroidism as a preventive measure, just as we screen newborns for congenital hypothyroidism to prevent the conditions harmful effects."
The experts described why maternal thyroid hormone is so important to the developing fetus. Gabriella Morreale de Escobar, MD, of the Instituto de Investigaciones Biomedicas, "Alberto Sols," in Madrid, Spain, explained that the fetus depends solely on the mother in the first half of gestation for thyroid hormone, especially thyroxine, needed for the developing brain. She added that pregnant women who are underproducing thyroxine are, therefore, at risk of having children with lower IQs and learning problems, such as attention-deficit hyperactivity disorder, whether or not their circulating thyroid-stimulating hormone (TSH) concentrations are increased. The most frequent cause of the inability of the maternal thyroid to produce enough thyroxine for fetal brain development is an inadequate supply of iodine. Amounts of this micronutrient, a necessary component of thyroid hormone, are needed with the onset of pregnancy and are almost double those needed by children and non-pregnant adults. "Intellectual impairments of many children could be easily prevented by promoting the use of iodine supplements taken before pregnancy throughout gestation and lactation," Dr. Morreale said.
The ATA statement concurs, emphasizing that pregnant and nursing women should take daily vitamin supplements that contain iodine, at least 220 micrograms a day for pregnant women and 290 micrograms daily for lactating women. Experts caution that only 35 percent of prenatal vitamins contain iodine. Worldwide, iodine deficiency remains the major factor responsible for intellectual impairment, although, in the United States, says the ATA statement, iodine nutrition is adequate. Even so, the statement goes further to say that new data indicate that some U.S. women of reproductive age may be at risk for slightly deficient intake. Furthermore, the ATA believes there is a need for research to clarify the iodine nutrition status of pregnant women in the United States, including measuring iodine levels in breast milk and correlating with maternal iodine nutrition and factors such as smoking.


